Progyny, Inc. Reports Financial Results for the Third Quarter of 2026

Progyny reported third-quarter 2026 adjusted EBITDA of $58.4 million, up 6.3% from $55.0 million a year earlier. For the fourth quarter, the company projects revenue of $344.7 million to $364.7 million, representing growth of 8.3% to 14.6%, and net income of $28.5 million to $32.1 million, or $0.36 to $0.41 per diluted share. Progyny expects fourth-quarter adjusted EBITDA of $57.9 million to $62.9 million and adjusted earnings per diluted share of $0.53 to $0.58.